Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Seed | Dead

Total Raised


Last Raised


About Copenhagen Biotech Assets

Developer of patent, discovery, and commercial activities based within the area of protein misfolding. The company focuses on bovine spongiforme encephalopathies (BSE) diagnostic assays and plans to develop drugs against BSE and other plaque related diseases such as Alzheimer's disease.

Copenhagen Biotech Assets Headquarter Location

Valleroed Banevej 42 2960 Rungsted


45 45863238

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.